Clinical Profile of Morbidly Adherent Placenta
Clinical Profile of Morbidly Adherent Placenta
DOI:
https://doi.org/10.70284/njirm.v8i3.1241Keywords:
Caesarean, caesarean hysterectomy, conservative management, embolization, methotrexate, morbidly adherent placenta, placenta accreta, placenta percretaAbstract
Background & Objectives: To present our experience of antenatally diagnosed morbidly adherent placenta and the success of the conservative management of morbidly adherent placenta in preserving the uterus and also in decreasing the maternal morbidity. Methods: Morbidly adherent placenta was diagnosed antenatally by ultrasound doppler. The women were followed till delivery. Treatment strategies ranged from a caesarean hysterectomy to leaving the placenta in situ with or without internal artery ligation/uterine artery embolisation and/or methotrexate therapy. Eleven cases of morbidly adherent placenta were managed successfully conservatively by leaving the placenta in situ followed by uterine artery embolisation and methotrexate therapy. The patients were followed with ultrasound doppler examination and serum beta-human chorionic gonadotrophin (β-hCG) level. Evacuation was done with complete removal of the placental tissue. Results: Morbidly adherent placenta was diagnosed antenatally by ultrasound doppler in 29 patients. History of previous one caesarean was present in 16 (55.1%) and two or more in 7 (24.1%), previous abortion in 4 (13.7%) and previous vaginal delivery in 2 (6.8%) women. Placenta was partially separated in 10 (34.4%) and retained in 11 (37.9%). 8(27.5%) women underwent emergency obstetric hysterectomies in whom the histology confirmed the diagnosis. 11 (37.9%) cases were managed successfully conservatively by leaving the placenta in situ with uterine artery embolisation and methotrexate therapy. Conclusions: Prenatal imaging may be very useful in antenatal diagnosis of adherent placenta. Efforts to minimize blood loss, planning the type of surgery, selective arterial embolization and uterine and/or hypogastric artery ligation, leaving the placenta in situ without attempts to remove and postpartum management with methotrexate therapy is more acceptable option in selected cases. [Shweta G NJIRM 2017; 8(3):36-40]
References
2. Tong SYP, Tay KH, Kwek YCK. Conservative management of placenta accreta: review of three cases. Singapore Medical Journal 2008; 49(6):e156–e159.
3. Wu S, Kocherginsky M, Hibbard JU. Abnormal placentation: twenty-year analysis. Am J Obstet Gynecol 2005;192:1458-61. 4. O’Brien JM, Barton JR, Donaldson ES. The management of placenta percreta: conservative and operative strategies. Am J Obstet Gynecol 1996;175:1632–8.
5. Eller AG, Porter TF, Soisson P, Silver RM. Optimal management strategies for placenta accreta. BJOG 2009;116:648-54.
6. Warshak CR, Ramos GA, Eskander R, Benirschke K, Saenz CC, Kelly TF et al. Effect of predelivery diagnosis in 99 consecutive cases of placenta accreta. Obstet Gynecol 2010;115:65-9.
7. Abuhamad A. Morbidly adherent placenta. Semin Perinatol 2013;37:359-64. 8. Silver RM, Landon MB, Rouse DJ, Leveno KJ, Spong CY, Thom EA et al. Maternal morbidity associated with multiple repeat cesarean deliveries. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Obstet Gynecol 2006;107:1226–32.
9. Editorial. Cesarean section on the rise. Lancet 2000;356;1697.
10. Mukherjee SN. Rising cesarean section rate. J Obstet Gynecol India 2006;56(4): 298-300. 11. Comstock CH. Antenatal diagnosis of placenta accreta: a review. Ultrasound Obstet Gynecol 2005;26:89–96.
12. Wong HS, Zucollo J, Parker S, Burns K, Tait J, Pringle KC. Antenatal diagnosis of non-previa placenta increta with histological confirmation. Ultrasound Obstet Gynecol 2006;27:467–469.
13. Taipale P, Orden MR, Berg Marja, Manninen H, Alafuzoff I. Prenatal diagnosis of placental accreta
and percreta with ultrasonography, color Doppler, and magnetic resonance imaging. Obstet Gynecol 2004;104:537–540. 14. Lam G, Kuller J, McMahon M. Use of magnetic resonance imaging and ultrasound in the antenatal diagnosis of placenta accrete. J Soc Gynecol Invest 2002;9:37–40.
15. Shellock FG, Crues JV. MRI procedures: biologic effects, safety and patient care. Radiology 2004;232:635.
16. Oyelese Y, Smulian JC. Placenta previa, placenta accreta and vasa previa. Obstet Gynecol 2006;107:927–941.
17. Dwyer BK, Belogolovkin V, Tran L, Rao A, Carroll I, Barth R, Chitkara U. Prenatal Diagnosis of Placenta Accreta: Sonography or Magnetic Resonance Imaging? J Ultrasound Med 2008;27(9): 1275–1281.
18. ACOG Committee on Obstetric Practice (2002) ACOG Committee opinion. Number 266, January 2002: placenta accreta. Obstet Gynecol 2002;99(1):169–170.
19. Alanis M, Hurst BS, Marshburn PB, Matthews ML. Conservative management of placenta increta with selective arterial embolization preserves future fertility and results in a favorable outcome in subsequent pregnancies. Fertil Steril 2002;86(5):1514.e3– 1514.e7.
20. Timmermans S, van Hof AC, Duvekot JJ. Conservative management of abnormally invasive placentation. Obstet Gynecol Surv 2007; 62(8):529–539.
21. Singh Y, Raghav V, Kapur A. Medical Management of Placenta Accreta with Methotrexate: Review of Two Cases. Journal of South Asian Federation of Obstetrics and Gynaecology 2015;7(2):01-03.
22. Raju M, Malik S, Mittal A. Methotrexate therapy for placenta accreta - A rare case report. Curr Pediatr Res 2010; 14(1): 69-70.
23. Sentilhes L, Ambroselli C, Kayem G, Provansal M, Fernandez H, Perrotin F et al. Maternal outcome after conservative treatment of placenta accreta. Obstet Gynecol 2010;115(3):526–534.
24. Matsumura N, Inoue T, Fukuoka M, Sagawa N, Fujii S. Changes in the serum levels of human chorionic gonadotropin and the pulsatility index of uterine arteries during conservative management of retained adherent placenta. J Obstet Gynaecol Res 2000;26(2):81–87.
25. HatWeld JL, Brumsted JR, Cooper BC. Conservative treatment of placenta accreta. J Minim Invasive Gynecol 2006;13(6):510– 513.
26. Takeda A, Koyama K, Imoto S, Mori M, Nakano T, Nakamura H. Conservative management of placenta increta after first trimester abortion by transcatheter arterial chemoembolization: a case report and review of the literature. Arch Gynecol Obstet 2010;281(3):381–386.
27. Gupta JK, Sinha AS, Lumsden MA, Hickey M. Uterine artery embolization for symptomatic uterine fibroids. Cochrane Database Syst Rev 2006; 25(1):CD005073.
